Controlling effects after 5ht2a agonists administration
OwnerMatthias Emanuel LIECHTIinventor
Life of this patent
Estimating the term…
Abstract
A composition for treating an individual while reducing acute effects, including effective amounts of a psychedelic drug and a duration shortening agent. A method of treating an individual with a psychedelic drug and reducing its acute duration of action, by administering a psychedelic drug to the individual, administering a duration shortening agent to the individual, and shortening and/or reducing the acute effects of the psychedelic drug. A method of stopping the acute duration of action of a psychedelic drug in an individual, by administering a duration shortening agent to the individual after the individual has taken a psychedelic drug and stopping the acute effects of the psychedelic drug.
Claims33
A composition for treating an individual while reducing acute effects, comprising effective amounts of a psychedelic drug and a duration shortening agent.
A method of treating an individual with a psychedelic drug and reducing its acute duration of action, including the steps of:
- administering a psychedelic drug to the individual;
- administering a duration shortening and/or effect blocking agent to the individual;
- and
- shortening and/or reducing the acute effects of the psychedelic drug.
A method of stopping the acute duration of action of a psychedelic drug in an individual, including the steps of:
- administering a duration shortening and/or effect reducing agent to the individual after the individual has taken a psychedelic drug;
- and
- stopping the acute effects of the psychedelic drug.
Dependencies are inferred from the claim text.